• SENSEX
    NIFTY 50
Business

Pharma earnings preview: Q2 likely to be subdued due to regulatory concerns

Updated : October 11, 2019 05:57 PM IST

Q2FY20 earnings are likely to moderate after three-quarters of a continuous uptrend
Sales are estimated to grow from 9 to 12 percent

You May Also Like

Live TV
Advertisement